NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 58 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $33,000 | +22.2% | 21,200 | +101.3% | 0.00% | – |
| Q3 2020 | $27,000 | -79.5% | 10,534 | -71.9% | 0.00% | – |
| Q2 2020 | $132,000 | +61.0% | 37,464 | -0.8% | 0.00% | – |
| Q1 2020 | $82,000 | +412.5% | 37,776 | +234.3% | 0.00% | – |
| Q2 2019 | $16,000 | -64.4% | 11,300 | -49.9% | 0.00% | – |
| Q1 2019 | $45,000 | -43.0% | 22,547 | -59.2% | 0.00% | – |
| Q4 2018 | $79,000 | -72.4% | 55,208 | -52.5% | 0.00% | – |
| Q3 2018 | $286,000 | -62.5% | 116,109 | -35.6% | 0.00% | -100.0% |
| Q2 2018 | $763,000 | 0.0% | 180,207 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $763,000 | +49.0% | 180,207 | +16.2% | 0.00% | -50.0% |
| Q4 2017 | $512,000 | -24.6% | 155,090 | -12.8% | 0.00% | -33.3% |
| Q3 2017 | $679,000 | -4.1% | 177,797 | +15.4% | 0.00% | -25.0% |
| Q2 2017 | $708,000 | +111.3% | 154,068 | +69.7% | 0.00% | +300.0% |
| Q1 2017 | $335,000 | – | 90,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEDBUSH SECURITIES INC | 247,911 | $1,049,000 | 0.14% |
| Willow Creek Wealth Management Inc. | 17,562 | $74,000 | 0.04% |
| WEBSTER BANK, N. A. | 50,000 | $212,000 | 0.03% |
| Brown Advisory Securities, LLC | 28,000 | $118,000 | 0.02% |
| Sterling Investment Advisors, Ltd. | 2,500 | $11,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $106,000 | 0.00% |
| AE Wealth Management LLC | 10,000 | $42,000 | 0.00% |
| SIMPLEX TRADING, LLC | 9,653 | $40,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 51,397 | $217,000 | 0.00% |
| LS Investment Advisors, LLC | 3,000 | $13,000 | 0.00% |